Heterogeneity impacts biomarker discovery for precision medicine
Kenneth Smith, View ORCID ProfileSharlee Climer
doi: https://doi.org/10.1101/2022.02.14.22270972
Kenneth Smith
1University of Missouri – St. Louis, Missouri, USA
Sharlee Climer
1University of Missouri – St. Louis, Missouri, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted August 01, 2022.
Heterogeneity impacts biomarker discovery for precision medicine
Kenneth Smith, Sharlee Climer
medRxiv 2022.02.14.22270972; doi: https://doi.org/10.1101/2022.02.14.22270972
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2840)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4421)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2847)
- Health Policy (1047)
- Hematology (374)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4183)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6772)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)